Reuters UK Business

(Reuters) -Stellantis is recalling 123,396 vehicles in the U.S. due to detached trim pieces on the driver and passenger windows that can create a road hazard for other vehicles, increasing the risk of a crash, the U.S. National Highway Traffic Safety Administration (NHTSA) said on Saturday. The quarter trim on the driver and passenger windows …

Stellantis to recall over 123,000 U.S. vehicles over risk of detached trim pieces Read More »

(Reuters) -The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times reported on Friday, hoping to defuse one of U.S. President Donald Trump’s top complaints after he announced steep tariff increases on branded medication. British Prime Minister Keir Starmer’s chief business adviser, Varun Chandra, …

UK to offer to pay more for some drugs to appease Trump, FT reports Read More »

By Jarrett Renshaw WASHINGTON (Reuters) -Britain would face 100% tariffs on pharmaceuticals imported into the U.S. under President Donald Trump’s latest plan, sources told Reuters on Friday. Trump announced on Thursday that he was imposing a 100% tariff that would apply to firms unless they build a manufacturing presence in the United States. The European …

Britain would face 100% tariff on pharmaceuticals under latest Trump plan, sources say Read More »

SEVASTOPOL, Crimea (Reuters) -A long queue of cars outside a petrol station in Sevastopol, a port city in Russian-controlled Crimea, laid bare the challenges drivers across Russia are facing in a widening gasoline crisis. As Ukraine has stepped up drone attacks on Russian refineries and export terminals in recent weeks, motorists are feeling the bite. …

Russian fuel crisis causes long queues and headaches for motorists Read More »

BRUSSELS (Reuters) -Dutch bank ING said on Friday it was facing a delay completing the previously announced sale of its Russian division to Global Development JSC. “At the time, it was expected that the transaction would be completed in the third quarter of 2025, subject to various regulatory approvals. Since the buyer has not received …

ING facing delay in completing the sale of its Russian unit Read More »

By Paul Arnold ZURICH (Reuters) -Swiss companies Roche and Novartis on Friday flagged they did not expect to be hit by President Donald Trump’s latest pharmaceutical tariff announcement because they are in the process of building new U.S. sites and investing there. Trump said on Thursday the United States will impose a 100% tariff on …

Roche, Novartis underline U.S. plans after Trump pharma tariff announcement Read More »

LONDON (Reuters) -Bank of England interest rate-setter Swati Dhingra said Britain’s high inflation rate is likely to ease off and the central bank should move more quickly to cut borrowing costs. “The effects of the shocks driving the UK’s current high inflation relative to Europe will fade, and thus, we should not be overly cautious …

Bank of England’s Dhingra calls for faster interest rate cuts Read More »